Dr. Weitzman on Sequencing Challenges in Myeloma Treatment
James Weitzman, MD, medical oncologist, Emerson Hospital and Waltham Cancer Center of Massachusetts General Cancer Center, discusses sequencing challenges in multiple myeloma treatment.
James Weitzman, MD, discusses sequencing challenges in multiple myeloma treatment.
Dr. Weitzman on Reusing Treatments in Relapsed/Refractory Multiple Myeloma
James Weitzman, MD, discusses reusing treatments in patients with relapsed/refractory multiple myeloma.
Dr. Weitzman on Challenges of Treating Penta-Refractory Multiple Myeloma
James Weitzman, MD, discusses the challenges of treating patients with penta-refractory multiple myeloma.
Dr Berkenstock on ADC-Related Ocular Toxicities in Cervical and Ovarian Cancers
Dr Matalonis on the Management of Mirvetuximab Soravtansine-Related Toxicities in FRα+ Ovarian Cancer
Updated EMPOWER-Lung 3 Data Support Frontline Cemiplimab Plus Chemo in Advanced NSCLC
Neoadjuvant Nivolumab Plus Chemotherapy Retains EFS Advantage in Resectable NSCLC
2 Clarke Drive Cranbury, NJ 08512